美国豁免马来酸酐残留限量要求（Maleic Anhydride; Exemption From the Requirement of a Tolerance）

ACTION

Final Rule.

SUMMARY

This regulation establishes an exemption from the requirement of a tolerance for residues of maleic anhydride (CAS Reg. No. 108-31-6) when used as an inert ingredient (stabilizer) in pesticide formulations applied to growing crops at a maximum co ncentration not to exceed 3.5% by weight in the pesticide formulation. Exponent, on behalf of Cheminova A/S, submitted a petition to EPA under the Federal Food, Drug, and Cosmetic Act (FFDCA), requesting an amendment to an existing requirement of a tolerance. This regulation eliminates the need to establish a maximum permissible level for residues of maleic anhydride.

TABLE OF CONTENTS

Back to Top

DATES:

ADDRESSES:

FOR FURTHER INFORMATION CONTACT:

SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

B. How can I get electro nic access to other related information?

C. How can I file an objection or hearing request?

II. Petition for Exemption

III. Inert Ingredient Definition

IV. Aggregate Risk Assessment and Determination of Safety

A. Toxicological Profile

B. Toxicological Points of Departure/Levels of Concern

C. Exposure Assessment

D. Safety Factor for Infants and Children

E. Aggregate Risks and Determination of Safety

V. Other Considerations

A. Analytical Enforcement Methodology

B. Revisions to Petitioned-For Tolerances

VI. Conclusions

VII. Statutory and Executive Order Reviews

VIII. Co ngressional Review Act

List of Subjects in 40 CFR Part 180

PART 180—[AMENDED]

TABLES

Back to Top

?

DATES:

Back to Top

This regulation is effective May 19, 2016. Objections and requests for hearings must be received on or before July 18, 2016, and must be filed in accordance with the instructions provided in 40 CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).

ADDRESSES:

Back to Top

The docket for this action, identified by docket identification (ID) number EPA-HQ-OPP-2014-0853, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory Public Docket (OPP Docket) in the Enviro nmental Protection Agency Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334, 1301 Co nstitution Ave. NW., Washington, DC 20460-0001. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Mo nday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is (202) 566-1744, and the telephone number for the OPP Docket is (703) 305-5805. Please review the visitor instructions and additio nal information a bout the docket available at http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT:

Back to Top

Susan Lewis, Registration Division (7505P), Office of Pesticide Programs, Enviro nmental Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; main telephone number: (703) 305-7090; email address: RDFRNotices@epa.gov.

SUPPLEMENTARY INFORMATION:

Back to Top

I. General Information

Back to Top

A. Does this action apply to me?

You may be potentially affected by this action if you are an agricultural producer, food manufacturer, or pesticide manufacturer. The following list of North American Industrial Classification System (NAICS) codes is not intended to be exhaustive, but rather provides a guide to help readers determine whether this docu ment applies to them. Potentially affected entities may include:

Crop production (NAICS code 111).

Animal production (NAICS code 112).

Food manufacturing (NAICS code 311).

Pesticide manufacturing (NAICS code 32532).

B. How can I get electro nic access to other related information?

You may access a frequently updat ed electro nic version of 40 CFR part 180 through the Government Printing Office's e-CFR site at http://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl. To access the OCSPP test guidelines referenced in this docu ment electronically, please go to http://www.epa.gov/ocspp and select “Test Methods and Guidelines.”

C. How can I file an objection or hearing request?

Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an objection to any aspect of this regulation and may also request a hearing on those objections. You must file your objection or request a hearing on this regulation in accordance with the instructions provided in 40 CFR part 178. To ensure proper receipt by EPA, you must identify docket ID number EPA-HQ-OPP-2014-0853 in the subject line on the first page of your submission. All objections and requests for a hearing must be in writing, and must be received by the Hearing Clerk on or before July 18, 2016. Addresses for mail and hand delivery of objections and hearing requests are provided in 40 CFR 178.25(b).

In addition to filing an objection or hearing request with the Hearing Clerk as described in 40 CFR part 178, please submit a copy of the filing (excluding any Co nfidential Business Information (CBI)) for inclusion in the public docket. Information not marked co nfidential pursuant to 40 CFR part 2 may be disclosed publicly by EPA without prior notice. Submit the non-CBI copy of your objection or hearing request, identified by docket ID number EPA-HQ-OPP-2014-0853, by one of the following methods:

Federal eRulemaking Portal: http://www.regulations.gov. Follow the o nline instructions for submitting comments. Do not submit electro nically any information you co nsider to be CBI or other information whose disclosure is restricted by statute.

Mail: OPP Docket, Enviro nmental Protection Agency Docket Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC 20460-0001.

Hand Delivery: To make special arrangements for hand delivery or delivery of boxed information, please follow the instructions at http://www.epa.gov/dockets/contacts.html. Additio nal instructions on commenting or visiting the docket, along with more information a bout dockets generally, is available at http://www.epa.gov/dockets.

II. Petition for Exemption

Back to Top

In the Federal Register of April 6, 2015 (80 FR 18327) (FRL-9924-00), EPA issued a docu ment pursuant to FFDCA section 408, 21 U.S.C. 346a, announcing the filing of a pesticide petition (PP) IN-10771 by Expo nent on behalf of Cheminova A/S, 1600 Wilson Boulevard, Suite 700, Arlington, VA 22209. The petition requested that 40 CFR 180.920 be amended by modifying an exemption from the requirement of a tolerance for residues of maleic anhydride (CAS Reg. No. 108-31-6) when used as an inert ingredient (stabilizer) in pesticide formulations applied to growing crops to allow for use at a maximum co ncentration not to exceed 5% in formulation. That docu ment referenced a summary of the petition prepared by Exponent, the petitioner, which is available in the docket, http://www.regulations.gov. There were no comments received in respo nse to the notice of filing.

ba sed upon review of the data supporting the petition, EPA has modified the limitation on the maximum co ncentration in pesticide formulation from 5% to 3.5%. This limitation is ba sed on the Agency's risk assessment which can be found at http://www.regulations.gov in docu ment, Maleic Anhydride; Human Health Risk Assessment and Ecological Effects Assessment to Support Proposed Exemption from the Requirement of a Tolerance When Used as an Inert Ingredient in Pesticide Products under 40 CFR 180.920, in docket ID number EPA-HQ-OPP-2014-0853.

III. Inert Ingredient Definition

Back to Top

Inert ingredients are all ingredients that are not active ingredients as defined in 40 CFR 153.125 and include, but are not limited to, the following types of ingredients (except when they have a pesticidal efficacy of their own): Solvents such as alcohols and hydrocarbons; surfactants such as polyoxyethylene polymers and fatty acids; carriers such as clay and diatomaceous earth; thickeners such as carrageenan and modified cellulose; wetting, spreading, and dispersing agents; propellants in aerosol dispensers; microencapsulating agents; and emulsifiers. The term “inert” is not intended to imply nontoxicity; the ingredient may or may not be chemically active. Generally, EPA has exempted inert ingredients from the requirement of a tolerance ba sed on the low toxicity of the individual inert ingredients.

IV. Aggregate Risk Assessment and Determination of Safety

Back to Top

Section 408(c)(2)(A)(i) of FFDCA allows EPA to establish an exemption from the requirement for a tolerance (the legal limit for a pesticide chemical residue in or on a food) o nly if EPA determines that the tolerance is “safe.” Section 408(b)(2)(A)(ii) of FFDCA defines “safe” to mean that “there is a reaso nable certainty that no harm will result from aggregate exposure to the pesticide chemical residue, including all anticipated dietary exposures and all other exposures for which there is reliable information.” This includes exposure through drinking water and in residential settings, but does not include occupatio nal exposure. Section 408(b)(2)(C) of FFDCA requires EPA to give special co nsideration to exposure of infants and children to the pesticide chemical residue in establishing a tolerance and to “ensure that there is a reaso nable certainty that no harm will result to infants and children from aggregate exposure to the pesticide chemical residue. . . .”

EPA establishes exemptions from the requirement of a tolerance o nly in those cases wher e it can be clearly demo nstrated that the risks from aggregate exposure to pesticide chemical residues under reaso nably foreseeable circumstances will pose no appreciable risks to human health. In order to determine the risks from aggregate exposure to pesticide inert ingredients, the Agency co nsiders the toxicity of the inert in co njunction with possible exposure to residues of the inert ingredient through food, drinking water, and through other exposures that occur as a result of pesticide use in residential settings. If EPA is able to determine that a finite tolerance is not necessary to ensure that there is a reaso nable certainty that no harm will result from aggregate exposure to the inert ingredient, an exemption from the requirement of a tolerance may be established.

Co nsistent with FFDCA section 408(c)(2)(A), and the factors specified in FFDCA section 408(c)(2)(B), EPA has reviewed the available scientific data and other relevant information in support of this action. EPA has sufficient data to assess the hazards of and to make a determination on aggregate exposure for maleic anhydride including exposure resulting from the exemption established by this action. EPA's assessment of exposures and risks associated with maleic anhydride follows.

A. Toxicological Profile

EPA has e valuated the available toxicity data and co nsidered their validity, completeness, and reliability as well as the relatio nship of the results of the studies to human risk. EPA has also co nsidered available information co ncerning the variability of the sensitivities of major identifiable subgroups of consumers, including infants and children. Specific information on the studies received and the nature of the adverse effects caused by maleic anhydride as well as the no-observed-adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-level (LOAEL) from the toxicity studies are discussed in this unit.

Maleic anhydride exhibits relatively low toxicity via oral and dermal routes of exposure. Maleic anhydride has been reported to be severely irritating to the skin and eyes of rabbits, dermally sensitizing to guinea pigs, and is a possible respiratory sensitizer.

In a six-mo nth repeat dose inhalation study, CD rats, Engle hamsters, and Rhesus mo nkeys were exposed by inhalation (whole body) to 0, 1.1, 3.3 and 9.8 mg/m3 (0, 0.3, 0.8, and 2.4 ppm) maleic anhydride for six months. Body weights were decreased in rats at 3.3 and 9.8 mg/m3 (0.8, and 2.4 ppm) in the mid- and high-exposure groups at intervals during the study (<10%). However, at study termination, body weights were decreased o nly at the 9.8 mg/m3 exposure group (6-8%). These decreases in the body weights are not co nsidered as an adverse effect. All other effects were limited to the respiratory tract and eye. All of these effects were co nsidered indicative of irritation and judged to be reversible. The NOAEL for irritation in this study was 3.3 mg/m3 or 0.93 mg/kg/day ba sed on localized eye/nasal irritation effects seen at the LOAEL of 9.8 mg/m3. The NOAEL for systemic toxicity in rats, hamsters and mo nkeys is 9.8 mg/m3, the highest dose tested.

In a 28-day inhalation study with maleic anhydride in Sprague-Dawley rats, evidence of nasal and ocular irritation (concentration-dependent) occurred at 12, 32 and 86 mg/m3. Reduced body weight gain and food co nsumption as well as increased incidence of hemorrhagic lung foci occurred at 32 and 86 mg/m3. The NOAEL for the systemic toxicity is 12 mg/m3 (3 ppm) ba sed on the reduced body weights and food co nsumption seen at the LOAEL of 32 mg/m3.

In a 90-day oral (dietary) study in rats were fed in the diet 0, 100, 250, or 600 mg/kg/day maleic anhydride for 90 days. At 600 mg/kg/day, there was slight proteinuria in both sexes, increased relative liver weight in males, increased relative/absolute kidney weights in both sexes. Macroscopic and microscopic kidney changes, including nephrosis were seen in male rats at 100, 250, and 600 mg/kg/day. The LOAEL for this study is 100 mg/kg/day. In a separate study, rats were fed in the diet 0, 20, or 40 mg/kg/day maleic anhydride, seven days a week for 90 days. There were no treatment-related effects. The NOAEL for this study is 40 mg/kg/day.

In a 183-day oral (dietary) study in rats there were renal lesions and an increase in the absolute and relative liver and kidney weights at 250 mg/kg/day and 600 mg/kg/day. The LOAEL for this study is 250 mg/kg/day. A NOAEL was not established.

In a 2-year oral (dietary) study in rats o nly marginal toxicity was observed which was evidenced by small (<6%), but dose-related, decrease in body weights of rats. The LOAEL for this study is 32 mg/kg/day and the NOAEL for this study is 10 mg/kg/day.

In a 90-day dietary study in dogs, there were no treatment related effects observed at doses up to 60 mg/kg/day, the highest dose tested.

In an oral (gavage) developmental toxicity study in CD rats, no treatment related adverse effects were observed. The NOAEL for both maternal and developmental toxicity was 140 mg/kg/day, the highest dose tested.

In a 2-generation oral (gavage) reproductive toxicity study in rats, significant mortality occurred in the F 0 and F 1 parental animals and maleic anhydride was toxic to parental animals in all dose groups (20, 55 and 150 mg/kg/day of maleic anhydride). There was no significant reduction in the percentage of pregnant females or the percentage of fertile males. Adverse effects on litter size and on pup survival were observed at the dose of 55 mg/kg/day and above in the F 2 litters. Maleic anhydride was toxic to parental animals in all dose groups. For parental toxicity the LOAEL was 20 mg/kg/day. Although a NOAEL for parental toxicity was not established, the selec ted NOAEL (which is from the 2-year toxicity study in the rat) will be protective of the kidney and bladder effects seen at the lowest dose tested in this study, since the 2-year toxicity study examined those organs and found no effects. The NOAEL for offspring toxicity was 55 mg/kg/day ba sed on decreased pup survival observed at 150 mg/kg/day.

Maleic anhydride was negative for mutagenicity or chromosomal aberrations in a battery of tests of genotoxicity including a bacterial gene mutation test, an in vivo mammalian chromosomal aberration test using rat bone marrow and an in vitro chromosomal test.

In the previously described 2-year dietary study, male and female rats were exposed to 0, 10, 32, or 100 mg/kg/day maleic anhydride in feed for two years. There were no increases in tumor incidence that were co nsidered related to maleic anhydride exposure. Additio nally in a two-year chro nic feeding study on Osborne-Mendel rats fed 0, 0.5, 1.0 or 1.5% maleic acid in their diets for two years resulted in no treatment-related increases in tumors.

A 1-hour neurotoxicity inhalation study exposed rats to 0.72 mg/L of maleic acid which produced generalized inactivity, hyperpnea and sedation within 15 minutes of exposure. Gross necropsy revealed no significant findings. No neurotoxic effects have been reported in the other available studies.

No immunotoxicity studies on maleic anhydride or maleic acid were available in the databa se.

In a me tabolism study, dogs were fed 60 mg/kg/day maleic anhydride for 90 days. Using a one compartment model, uptake rate and elimination rate co nstants were calculated as 3.49 × 10 ?3 per day and 8.32 × 10 ?2 per day, respectively. ba sed on this model, 99% of steady state was reached by day 55 of the study.

Maleic anhydride is readily hydrolyzed to maleic acid under aqueous co nditions and is then hydroxylated to malic acid, which participates in the Krebs cycle or may be excreted unchanged or in co njugated form.

B. Toxicological Points of Departure/Levels of Concern

o nce a pesticide's toxicological profile is determined, EPA identifies toxicological points of departure (POD) and levels of co ncern to use in e valuating the risk posed by human exposure to the pesticide. For hazards that have a threshold below which there is no appreciable risk, the toxicological POD is used as the basis for derivation of reference values for risk assessment. PODs are developed ba sed on a careful analysis of the doses in each toxicological study to determine the dose at which no adverse effects are observed (the NOAEL) and the lowest dose at which adverse effects of co ncern are identified (the LOAEL). Uncertainty/safety factors are used in co njunction with the POD to calculate a safe exposure level—generally referred to as a population-adjusted dose (PAD) or a reference dose (RfD)—and a safe margin of exposure (MOE). For non-threshold risks, the Agency assumes that any amount of exposure will lead to some degree of risk. Thus, the Agency estimates risk in terms of the probability of an occurrence of the adverse effect expected in a lifetime. For more information on the general principles EPA uses in risk characterization and a complete des cription of the risk assessment process, see http://www.epa.gov/pesticides/factsheets/riskassess.htm.

An acute effect was not found in the databa se for maleic anhdyride.

The 2-year oral toxicity study in rats was selec ted for dietary and dermal exposure scenarios (all non-acute durations) for this risk assessment. The NOAEL in this study was 10 mg/kg/day. The LOAEL was 32 mg/kg/day ba sed on slight to marginal decreases in body weight. The ratio nale for selecting this study for the dietary is ba sed on the fact that this study provided the lowest and most co nservative toxicity endpoint in the most sensitive species for oral after a long-term exposure. No repeat dose dermal toxicity studies are available for maleic anhydride; the dermal risk assessment was co nducted using the most sensitive co nservative oral endpoint. An uncertainty factor of 100x was applied, 10x for interspecies variability and 10x for intraspecies variability; the FQPA safety factor was reduced to 1x. No dermal absorption studies were available for maleic anhydride or maleic acid, therefore, a dermal absorption value was estimated using the ratio of an oral LD 50 and a dermal LD 50. The two studies used were the oral rabbit LD 50 of 875 mg/kg and the dermal rabbit LD 50 of 2,620 mg/kg. The resulting estimated dermal absorption was 33%. Therefore, a dermal absorption factor of 33% will be used for dermal exposure scenarios.

The 6-mo nth inhalation toxicity study in rats was selected for inhalation exposure scenarios (all durations) for this risk assessment. The NOAEL in this study was 3.3 mg/m3 or 0.93 mg/kg/day ba sed on localized eye/nasal irritation effects seen at the LOAEL of 9.8 mg/m3. Since the major effect of maleic anhydride is irritation via inhalation, this endpoint is protective of any systemic toxicity seen at co ncentrations of 32 mg/m3 and above seen in the 28-day inhalation toxicity study. An uncertainty factor of 100x was applied, 10x for interspecies variability and 10x for intraspecies variability. The FQPA safety factor was reduced to 1x.

C. Exposure Assessment

1. Dietary exposure from food and feed uses. In e valuating dietary exposure to maleic anhydride, EPA co nsidered exposure under the proposed exemption from the requirement of a tolerance. EPA assessed dietary exposures from maleic anhydride in food as follows:

i. Acute exposure. Quantitative acute dietary exposure and risk assessments are performed for a food-use pesticide chemical, if a toxicological study has indicated the possibility of an effect of co ncern occurring as a result of a 1-day or single exposure. No such effects were identified in the toxicological studies for maleic anhydride therefore, a quantitative acute dietary exposure assessment is unnecessary.

ii. Chro nic exposure. The chro nic dietary exposure assessment for this inert ingredient utilizes the Dietary Exposure e valuation Model Food Commodity Intake Databa se (DEEM—FCID), Version 3.16, EPA, which includes food co nsumption information from the U.S. Department of Agriculture's Natio nal Health and Nutrition Examination Survey, “What We Eat In America”, (NHANES/WWEIA). This dietary survey was co nducted from 2003 to 2008. In the absence of actual residue data, the inert ingredient e valuation is ba sed on a highly co nservative model which assumes that the residue level of the inert ingredient would be no higher than the highest established tolerance for an active ingredient on a given commodity. Implicit in this assumption is that there would be similar rates of degradation between the active and inert ingredient (if any) and that the co ncentration of inert ingredient in the scenarios leading to these highest of tolerances would be no higher than the co ncentration of the active ingredient. The model assumes 100 percent crop treated (PCT) for all crops and that every food eaten by a person each day has tolerance-level residues. A complete des cription of the general approach taken to assess inert ingredient risks in the absence of residue data is co ntained in the memorandum entitled “Alkyl Amines Polyalkoxylates (Cluster 4): Acute and Chro nic Aggregate (Food and Drinking Water) Dietary Exposure and Risk Assessments for the Inerts.” (D361707, S. Piper, 2/25/09) and can be found at http://www.regulations.gov in docket ID number EPA-HQ-OPP-2008-0738. In the case of maleic anhydride, EPA made specific adjustments to the dietary exposure assessment to account for the use limitation of maleic anhydride (as an inert ingredient in pesticide formulations applied to apples with a minimum preharvest interval of 21 days and at maximum co ncentration of 3.5% by weight in all other preharvest uses).

2. Dietary exposure from drinking water. For the purpose of the screening level dietary risk assessment to support this request for an exemption from the requirement of a tolerance for maleic anhydride, a co nservative drinking water co ncentration value of 100 ppb ba sed on screening level modeling was used to assess the co ntribution to drinking water for the chro nic dietary risk assessments for parent compound. These values were directly entered into the dietary exposure model.

3. From non-dietary exposure. The term “residential exposure” is used in this docu ment to refer to non-occupational, non-dietary exposure (e.g., textiles (clothing and diapers), carpets, swimming pools, and hard surface disinfection on walls, floors, tables).

Maleic anhydride may be used as inert ingredient in pesticide products that are registered for specific uses that may result in indoor or outdoor residential inhalation and dermal exposures. A screening-level residential exposure and risk assessment was completed utilizing co nservative residential exposure assumptions. The Agency assessed short- and intermediate-term dermal and inhalation exposures for residential handlers that would result from low pressure handwand, hose end sprayer and trigger sprayer for outdoor scenarios of each pesticide type, herbicide, insecticide and fungicide and mopping, wiping and aerosol sprays for indoor scenarios. The Agency assessed post-application short-term dermal exposure for children and adults as well as short-term hand-to-mouth exposure for children from co ntact with treated lawns.

4. Cumulative effects from substances with a common mechanism of toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when co nsidering whether to establish, modify, or revoke a tolerance, the Agency co nsider “available information” co ncerning the cumulative effects of a particular pesticide's residues and “other substances that have a common mechanism of toxicity.”

EPA has not found maleic anhydride to share a common mechanism of toxicity with any other substances, and maleic anhydride does not appear to produce a toxic me tabolite produced by other substances. For the purposes of this tolerance action, therefore, EPA has assumed that maleic anhydride does not have a common mechanism of toxicity with other substances. For information regarding EPA's efforts to determine which chemicals have a common mechanism of toxicity and to e valuate the cumulative effects of such chemicals, see EPA's Web site at http://www.epa.gov/pesticides/cumulative.

D. Safety Factor for Infants and Children

1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA shall apply an additio nal tenfold (10x) margin of safety for infants and children in the case of threshold effects to account for prenatal and postnatal toxicity and the completeness of the databa se on toxicity and exposure unless EPA determines ba sed on reliable data that a different margin of safety will be safe for infants and children. This additio nal margin of safety is commo nly referred to as the FQPA Safety Factor (SF). In applying this provision, EPA either retains the default value of 10x, or uses a different additio nal safety factor when reliable data available to EPA support the choice of a different factor.

2. Prenatal and postnatal sensitivity. There is no evidence of increased quantitative or qualitative susceptibility of rat fetuses to the effects of maleic anhydride. In the 2-generation reproduction study, the LOAEL for parental toxicity was 20 mg/kg/day. No adverse effects on litter size or pup survival were noted at doses up to 55 mg/kg/day.

3. Conclusion. EPA has determined that reliable data show the safety of infants and children would be adequately protected if the FQPA SF were reduced to 1x. That decision is ba sed on the following findings:

i. The toxicity databa se for maleic anhydride is adequate for characterizing the toxicity and assessing the risk from dietary exposure.

ii. There is no indication that maleic anhydride is a neurotoxic chemical and there is no need for a developmental neurotoxicity study or additio nal UFs to account for neurotoxicity.

iii. There is no indication that maleic anhydride is an immunotoxic chemical and there is no need for an immunotoxicity study or additio nal UFs to account for immunotoxicity.

iv. There is no evidence that maleic anhydride results in increased susceptibility in in utero in rats in the combined repeated dose toxicity study with the reproduction/developmental toxicity screening studies and prenatal developmental studies.

v. There are no residual uncertainties identified in the exposure databa ses. The dietary food exposure assessments were performed ba sed on highly co nservative model that assumes 100 percent crop treated (PCT) for all crops and that every food eaten by a person each day has residues of inert ingredient equivalent to the residue level of the highest established tolerance for an active ingredient on a given commodity. EPA made co nservative (protective) assumptions in the ground and surface water modeling used to assess exposure to maleic anhydride in drinking water. EPA used similarly co nservative assumptions to assess post application exposure of children as well as incidental oral exposure of toddlers. These assessments will not underestimate the exposure and risks posed by maleic anhydride.

E. Aggregate Risks and Determination of Safety

EPA determines whether acute and chro nic dietary pesticide exposures are safe by comparing aggregate exposure estimates to the acute PAD (aPAD) and chro nic PAD (cPAD). For linear cancer risks, EPA calculates the lifetime probability of acquiring cancer given the estimated aggregate exposure. Short-, intermediate-, and chronic-term risks are e valuated by comparing the estimated aggregate food, water, and residential exposure to the appropriate PODs to ensure that an adequate MOE exists.

1. Acute risk. An acute aggregate risk assessment takes into account acute exposure estimates from dietary co nsumption of food and drinking water. No adverse effect resulting from a single oral exposure was identified and no acute dietary endpoint was selec ted. Therefore, maleic anhydride is not expected to pose an acute risk.

2. Chro nic risk. Using the exposure assumptions described in this unit for chro nic exposure, EPA has co ncluded that chro nic exposure to maleic anhydride from food and water will utilize 72.4% of the cPAD for children 1-2 years old, the population group receiving the greatest exposure. ba sed on the explanation in this unit, regarding residential use patterns, chro nic residential exposure to residues of maleic anhydride is not expected.

3. Short-term risk. Short-term aggregate exposure takes into account short-term residential exposure plus chro nic exposure to food and water (co nsidered to be a background exposure level).

Maleic anhydride may be used as an inert ingredient in pesticide products that are registered for uses that could result in short-term residential exposure, and the Agency has determined that it is appropriate to aggregate chro nic exposure through food and water with short-term residential exposures to maleic anhydride.

Using the exposure assumptions described in this unit for short-term exposures, EPA has co ncluded the combined short-term food, water, and residential exposures result in aggregate MOEs of 112 for adults and 105 for children. Because EPA's level of co ncern for maleic anhydride is a MOE of 100 or below, these MOEs are not of concern.

4. Intermediate-term risk. Intermediate-term aggregate exposure takes into account intermediate-term residential exposure plus chro nic exposure to food and water (co nsidered to be a background exposure level).

Maleic anhydride is currently used as an inert ingredient in pesticide products that are registered for uses that could result in intermediate-term residential exposure, and the Agency has determined that it is appropriate to aggregate chro nic exposure through food and water with short-term residential exposures to maleic anhydride.

Using the exposure assumptions described in this unit for intermediate-term exposures, EPA has co ncluded the combined intermediate-term food, water, and residential exposures result in aggregate MOEs of 178 for adults and 119 for children. Because EPA's level of co ncern for maleic anhydride is a MOE of 100 or below, these MOEs are not of concern.

5. Aggregate cancer risk for U.S. population. ba sed on the discussion in Unit IV.A., maleic anhydride is not expected to pose a cancer risk.

6. Determination of safety. ba sed on these risk assessments, EPA co ncludes that there is a reaso nable certainty that no harm will result to the general population, or to infants and children from aggregate exposure to maleic anhydride residues.

V. Other Considerations

Back to Top

A. Analytical Enforcement Methodology

Although EPA is establishing a limitation on the amount of maleic anhydride that may be used in pesticide formulations, an analytical enforcement methodology is not necessary for this exemption. The limitation will be enforced through the pesticide registration process under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), 7 U.S.C. 136 et seq. EPA will not register any pesticide for sale or distribution for use on growing crops with co ncentrations of maleic anhydride exceeding 3.5% by weight of the formulation.

B. Revisions to Petitioned-For Tolerances

ba sed upon an e valuation of the data included in the petition, EPA is establishing an exemption from the requirement of a tolerance for residues of maleic anhydride when used in pesticide formulations as an inert ingredient (stabilizer), not to exceed 3.5% by weight of the formulation, instead of the 5% limit requested. The basis for this revision can be found at http://www.regulations.gov in docu ment Maleic Anhydride; Human Health Risk Assessment and Ecological Effects Assessment to Support Proposed Exemption from the Requirement of a Tolerance When Used as an Inert Ingredient in Pre-harvest Pesticide Products under 40 CFR 180.920 in docket ID number EPA-HQ-OPP-2014-0853.

VI. Conclusions

Back to Top

Therefore, EPA is amending the existing exemption from the requirement of a tolerance under 40 CFR 180.920 for maleic anhydride (CAS Reg. No. 108-31-6). In addition to the existing limitation for use as an inert ingredient (stabilizer) in pesticide formulations applied to growing crops for use in pesticide formulations applied to apples with a minimum preharvest interval of 21 days, the Agency is extending the exemption for use in all pesticide formulations at a maximum co ncentration not to exceed 3.5% in the pesticide formulation. In order to clarify that this extension applies o nly to maleic anhydride, the Agency is separating the existing exemption for maleic anhydride from the existing maleic acid exemption.